(PBMC) (Gartner et al., 1986; Ashorn et al., 1990; O'Brien et al., 1990; Schuitemaker et al., 1991) . On occasion, an Although the human hCCR-5 chemokine receptor can HIV-1 isolate able to infect both macrophages and T-cell serve as a co-receptor for both M-tropic (ADA and lines is observed, and these are referred to as dual tropic BaL) and dual-tropic (89.6) strains of human immuno- (Collman et al., 1992; Simmons et al., 1996) . deficiency virus type 1 (HIV-1), the closely related
Mapping of determinants of HIV-1 tropism demonmouse mCCR-5 homolog is inactive. We used chimeric strated that these were located in the viral envelope protein hCCR-5-mCCR-5 receptor molecules to examine the and were concentrated in the short V3 loop of envelope functional importance of the three extracellular (O'Brien et al., 1990; Hwang et al., 1991; Shioda et al. , domains of hCCR-5 that differ in sequence from their 1991; Westervelt et al., 1991) . It was therefore proposed mCCR-5 equivalents. While this analysis revealed that that infection by HIV-1 required a co-receptor, in addition all three of these extracellular domains could participto CD4, that was present on human but not on animal ate in the functional interaction with HIV-1 envelope, cells. In addition, it appeared that at least two distinct coclear differences were observed when different HIV-1 receptors must exist, one for T-tropic isolates and a strains were analyzed. Thus, while the ADA HIV-1 second specific for M-tropic isolates. Recent evidence has isolate could effectively utilize chimeric human-mouse validated this hypothesis and has identified the CXCR-4 CCR-5 chimeras containing any single human extrachemokine receptor, also termed fusin, as the predominant cellular domain, the BaL isolate required any two T-tropic HIV-1 co-receptor and the CCR-5 chemokine human extracellular sequences while the 89.6 isolate receptor as the dominant M-tropic co-receptor (Alkhatib would only interact effectively with chimeras con Choe et al., 1996; Deng et al., 1996 ; Doranz taining all three human extracellular sequences. Furet al., 1996; Dragic et al., 1996; Feng et al., 1996) . ther analysis using hybrid HIV-1 envelope proteins
Although the identification of specific co-receptors for showed that the difference in co-receptor specificity HIV-1 infection represents an important step forward, little displayed by the ADA and BaL isolates was due partly is known as yet about how they participate in envelopeto a single amino acid change in the V3 loop, although mediated fusion. Chemokine receptors are seven-memthis interaction was clearly also modulated by other brane-spanning, G-protein-coupled receptors that play a envelope domains. Overall, these data indicate that the role in the inflammatory response and in the recognition interaction between HIV-1 envelope and CCR-5 is not of chemotactic signals (Murphy, 1994) . At present, it is only complex but also subject to marked, HIV-1 isolatenot known how HIV-1 envelope proteins of different dependent variation. Trkola et al., 1996; Wu et al., 1996) . It also remains unclear why animal chemokine receptors, which Shortly after identification of the human CD4 glycoprotein are often very similar to their human equivalents, are as the primary receptor for human immunodeficiency virus nevertheless unable to mediate HIV-1 infection. type 1 (HIV-1), it became apparent that CD4 was not
Introduction
To address these issues, we have cloned cDNA copies sufficient to mediate infection (reviewed by Planelles of the human and mouse forms of the CCR-5 receptor et al., 1993; James et al., 1996) . In particular, it was and have generated a series of 14 chimeras between these observed that while expression of CD4 could render two closely related molecules. As predicted, mouse CCR-5 human cell lines susceptible to infection by laboratoryproved unable to function as an HIV-1 co-receptor. Indiadapted HIV-1 isolates, this was not true for the majority vidual substitution of either the amino-terminal extracelluof animal cells (Maddon et al., 1986; lar domain or the second extracellular loop of human 1991). Subsequent research using primary isolates of CCR-5 into mouse CCR-5 conferred efficient co-receptor HIV-1 revealed an even more complex picture. Thus, laboratory-adapted isolates of HIV-1, also referred to as function for the M-tropic HIV-1 isolate ADA. In contrast, infection by the M-tropic HIV-1 isolate BaL or the duallevels of SEAP activity were detected when COS cells tropic isolate 89.6 required functional interactions with transfected with the M-tropic BaL or the T-tropic IIIB multiple extracellular domains of human CCR-5. These provirus were mixed with COS cells transfected with data demonstrate that several distinct regions in human pBC12/HIV/SEAP alone, with cells transfected with the CCR-5 play a role in mediating HIV-1 infection and also indicator construct and a CD4 expression plasmid, or with suggest that HIV-1 isolates can differ in terms of which cells transfected with pBC12/HIV/SEAP and plasmids regions of the viral envelope participate in CCR-5 coexpressing either wild-type or HA-tagged forms of the receptor recognition.
human CCR-5 (hCCR-5) receptor. In contrast, readily detectable levels of SEAP were observed when BaL-, but not IIIB-, expressing cells were cultured in the presence
Results
of pBC12/HIV/SEAP transfected cells expressing both Both the human and the murine CCR-5 receptor are CD4 and wild-type hCCR-5 (Figure 2A ). Co-expression activated by the chemokines MIP-1α, MIP-1β and of CD4 and an amino-terminally HA-tagged form of RANTES, and both are expressed on macrophages (Boring hCCR-5 resulted in a very similar level of cell fusion, Samson et al., 1996) . While the human and hence activation of the SEAP indicator gene. In CCR-5 receptor is also expressed on primary T-cells, contrast, no activation of SEAP expression was detected this remains to be examined for its murine counterpart.
in cultures expressing CD4 and an HA-tagged form of Comparison of the predicted primary sequence of these murine CCR-5 (mCCR-5) upon co-culture with either two proteins reveals that they are 82% identical ( Figure  BaL -or IIIB-expressing cells. However, co-expression of 1A). The observed differences are generally conservative CD4 and an HA-tagged human CXCR-4 (HA-hCXCR-4) and are scattered throughout the protein, i.e. they are not chemokine receptor resulted, as predicted, in a marked concentrated in either the four predicted extracellular activation of SEAP expression upon co-cultivation with domains, the seven transmembrane domains or the four cells expressing the T-tropic IIIB, but not the M-tropic intracellular domains.
BaL, HIV-1 isolate ( Figure 2A ). Very similar results were To test whether the murine CCR-5 receptor would be also observed using the human cell line 293T, although able to substitute for the human CCR-5 receptor in these cells, like most human cells, constitutively express mediating HIV-1 envelope-induced cell fusion, we the T-tropic CXCR-4 co-receptor so that IIIB-induced designed a transient expression assay to quantitate fusion fusion is, in this context, only dependent on the addition efficiency. In this assay, one batch of cells (either human of CD4 (data not shown). Overall, we therefore conclude 293T or simian COS cells) was transfected with an HIV-1 that this transient assay accurately and specifically proviral expression plasmid encoding, for example, the measures the ability of different chemokine receptors to M-tropic BaL or the T-tropic IIIB envelope protein function as co-receptors for different isolates of HIV-1, (Gartner et al., 1986; Hwang et al., 1991) . At the same and further conclude that mCCR-5, despite its close time, a second batch of cells was transfected with expressimilarity to hCCR-5, is nevertheless unable to mediate sion vectors encoding human CD4, a candidate co-receptor fusion by either M-tropic or T-tropic HIV-1 envelope and an indicator construct (pBC12/HIV/SEAP) containing proteins. the HIV-1 long terminal repeat (LTR) linked to the secreted alkaline phosphatase (SEAP) indicator gene (Berger et al., Different regions of hCCR-5 can mediate fusion by 1988). This latter construct normally produces only very different HIV-1 isolates low levels of SEAP activity due to the low level of To map regions within the hCCR-5 receptor that mediate transcription driven by the basal HIV-1 LTR promoter.
HIV-1 infection, we next constructed a series of chimeras However, if this indicator construct is activated by the between HA-tagged forms of hCCR-5 and mCCR-5. As HIV-1 Tat trans-activator, high levels of SEAP will be indicated in Figure 1 , the CCR-5 receptor contains an secreted by the transfected cells.
amino-terminal extracellular tail as well as three extraAt 48 h after transfection, the cells transfected with the cellular loops, each of which could contribute to envelope HIV-1 provirus and the cells expressing CD4 and the binding and membrane fusion. In addition, the seven candidate HIV-1 co-receptors are harvested and plated transmembrane domains and four intracellular regions of together at a 1:1 ratio. During the subsequent 48 h period hCCR-5 could conceivably also participate in the fusion of co-culture, the pBC12/HIV/SEAP indicator construct process by, for example, promoting an appropriate receptor could be trans-activated by Tat due to infection of receptorconformation. expressing cells by virions released by the HIV-1 provirusInspection of the predicted sequences of hCCR-5 and expressing cells or, more probably, due to direct fusion mCCR-5 shows that they differ at 10 positions (including between cells expressing the HIV-1 provirus and cells a two amino acid insertion) in the~35 amino acid aminoexpressing HIV-1 receptors. Work from many laboratories terminal tail, at four positions in the~15 amino acid first has established that the receptor requirements for fusion extracellular loop and at six positions in the~31 amino to HIV-1 envelope-expressing cells are equivalent to the acid second loop. The~17 amino acid third loop is requirements for fusion with HIV-1 virions (Clapham predicted to be identical in both molecules. To construct et al., 1991; Deng et al., 1996; Doranz et al., 1996; Dragic chimeras between hCCR-5 and mCCR-5, we took advant Feng et al., 1996; Rucker et al., 1996) . age of conserved BglII and BsaBI restriction sites that flank the second extracellular loop and also used an EspI Murine CCR-5 is not a functional co-receptor for site located at the membrane-proximal end of the amino-HIV-1 terminal tail of mCCR-5 (Figure 1 ). Using these three A representative co-receptor assay using the simian COS cell line is presented in Figure 2A . Only low, background sites, we constructed a set of 14 chimeric molecules by Boring et al., 1996; Samson et al., 1996) are boxed and numbered. Extracellular sequences include the aminoterminal tail and three extracellular loops located between transmembrane domains II and III, IV and V and VI and VII, respectively. Conserved cysteines potentially involved in disulfide bond formation are indicated by black triangles, while a conserved glycosylation site in extracellular loop 3 is underlined. The location of restriction sites used in the production of chimeras is indicated.
(B) Schematic representation of the structure of the hCCR-5-mCCR-5 chimeras analyzed in this work.
interchange of four cassettes consisting of (i) the aminoin order. Thus, for example, HMHM contains the aminoterminal extracellular tail and the second extracellular terminal tail; (ii) the first extracellular loop, the first four transmembrane domains and the first and second loop of hCCR-5 in an otherwise mCCR-5 context. To determine the relative efficiency with which these intracellular regions; (iii) the second extracellular loop; or (iv) the conserved third extracellular loop, the last chimeric receptors could mediate HIV-1 envelope fusion, it was necessary first to demonstrate that the assay utilized three transmembrane domains and the third and carboxyterminal intracellular domains ( Figure 1B ). These chimeras was in the linear range. In fact, fusion between BaL envelope-expressing and CD4-expressing cells was were named according to the origin of these four segments, rate-limiting step in the process of HIV-1 envelopemediated cell fusion, and further conclude that the assay used here to measure hCCR-5 co-receptor function is not of these CCR-5 receptor chimeras to mediate HIV-1 Some receptors were modified by addition of an amino-terminal HA envelope fusion is whether they are expressed at the cell tag. Cells derived from each set were co-cultivated starting 48 h after surface at equivalent levels and in a native conformation. chimeric CCR-5 receptors ( Figure 1B ), using an anti-HA (C) Similar to (B), except that the dose-response was performed in tag antibody, is presented in Figure 3A . As may be 293T cells. observed, the parental mCCR-5 and hCCR-5 receptors, as well as 10 of the chimeric receptors, are expressed on the cell surface of transfected 293T cells at equivalent, readily observed to become increasingly efficient in both simian COS cells ( Figure 2B ) and human 293T cells ( Figure 2C ) detectable levels. In contrast, four of the chimeric receptors (MHMM, HHHM, HHMM and MHHM) were found to as the level of hCCR-5 expression was increased. We therefore conclude that, under these experimental condibe expressed at substantially lower levels that were only slightly above the negative control. tions, recruitment of the hCCR-5 co-receptor represents a An extensive analysis of hCCR-5 receptor function, which will be presented in detail elsewhere (I.Aramori, S.S.G.Ferguson, P.D.Bieniasz, B.R.Cullen and M.G.Caron, manuscript submitted), demonstrated that this receptor is coupled to inhibitory heterotrimeric G proteins and, as a result, is able to inhibit forskolin-stimulated cAMP accumulation effectively when activated by an appropriate chemokine. To assess whether the various chimeras retained CCR-5 receptor function, we therefore asked whether stimulation with the chemokine MIP-1β, which is specific for the CCR-5 receptor (Boring et al., 1996; Samson et al., 1996) , would inhibit forskolin-induced cAMP accumulation in transfected 293T cells (Salomon, 1991) . As shown in Figure 3B , MIP-1β activation of either the hCCR-5 or the mCCR-5 parental receptor inhibited cAMP production efficiently, as did binding to 10 of the 14 chimeric receptors. However, the four chimeric receptors found by FACS analysis to be expressed at low levels ( Figure 3A) were also found to be entirely inactive in this assay for receptor function. Interestingly, these four chimeric receptors each have human sequences in the second cassette and murine sequences in the fourth ( Figure 1B ), thus suggesting that there may be some structural incompatibility between these two regions. Further analysis demonstrated that all four of these nonfunctional receptor chimeras, including the HHHM chimera predicted to express extracellular domains identical to the parental hCCR-5 receptor, were entirely unable to mediate HIV-1 envelope fusion (data not shown). Therefore, these four chimeras were omitted from all further analysis.
To map regions in hCCR-5 involved in mediating HIV-1 infection, we measured the ability of HIV-1 envelope proteins derived from the M-tropic BaL and ADA isolates (Hwang et al., 1991; Westervelt et al., 1991) , the dualtropic 89.6 isolate (Collman et al., 1992) and the T-tropic IIIB isolate to fuse with COS cells expressing the two parental and 10 stable human-mouse hybrid CCR-5 receptors described in Figure 1B . These data are shown in Figure 4 and summarized in Table I .
The first three chimeras tested (HMMM, MMHM and MMMH) largely examine whether either the first or third Figure 4A , both the HMMM proteins. These data represent the average of three independent chimera and the MMHM chimera indeed proved able experiments, with the standard deviation indicated. Observed SEAP activities are given relative to the parental hCCR-5 co-receptor, which efficiently to mediate fusion with cells expressing the was arbitrarily designated as 100. No significant differences in the M-tropic ADA envelope. In contrast, no fusion was level of observed SEAP activity were observed when these three virus observed with the HMMM chimera, and minimal levels isolates were tested with wild-type hCCR-5 (data not shown).
with the MMHM chimera, when the M-tropic BaL isolate was tested ( Figure 4B ). As expected, neither M-tropic isolate was able to interact functionally with the MMMH sufficient to mediate fusion by the ADA envelope protein when expressed in an otherwise entirely mCCR-5 context chimera, which is predicted to have extracellular sequences identical to the parental mCCR-5 receptor. The dual-tropic on the surface of CD4 ϩ cells. In contrast, these two hCCR-5 sequences are clearly not sufficient individually 89.6 envelope ( Figure 4C ) and the T-tropic IIIB envelope each failed to interact with any of these three chimeras to mediate efficient fusion by the M-tropic BaL or the dualtropic 89.6 envelope when presented in the mCCR-5 when expressed in COS cells. Indeed, the IIIB envelope, as expected (Alkhatib et al., 1996; Deng et al., 1996;  context. The next set of three chimeras (MHHH, HMHH and Dragic et al., 1996) , failed to interact functionally with any chimeric CCR-5 receptor, and these data are therefore HHMH) test whether any single extracellular sequence in hCCR-5 is essential for fusion ( Figure 1B ). As shown in simply summarized in Table I . Overall, these first three chimeras demonstrate that either the amino-terminal tail Figure 4A and B, both the ADA and the BaL envelope proved able to fuse efficiently to cells expressing receptor or the second extracellular loop of hCCR-5 are fully 
This summary of the ability of different parental or chimeric chemokine receptors to mediate fusion with cells expressing different cloned HIV-1 envelope proteins is drawn from Figures 4 and 5. The data for ADA and BaL represent the average of data obtained using both COS and 293T cells, while the data for the other viruses are based entirely on experiments using COS cells. ϩϩ ϭ Ͼ50% of hCCR-5; ϩ ϭ 25-50% of hCCR-5 while Ϯ indicates marginal activity.
chimeras in which any of the first three extracellular unable to utilize any of these four chimeric CCR-5 receptors, although 89.6, unlike either ADA or BaL, did sequences of hCCR-5 were substituted with the equivalent mCCR-5 sequence. We therefore conclude that, for these prove able to fuse with cells expressing the T-tropic hCXCR-4 co-receptor ( Figure 4C ). two M-tropic viruses, no single extracellular loop in hCCR-5 is critical for fusion. In contrast, the dual-tropic 89.6 envelope interacted only inefficiently with the MHHH The HIV-1 co-receptor functions similarly in different cell contexts and HMHH chimeras and not at all with HHMH ( Figure  4C ). We therefore conclude that all three of these extraWhile the hCCR-5 co-receptor appears able to mediate fusion with HIV-1 envelope-expressing cells when cocellular sequences in hCCR-5 play a role in mediating 89.6 fusion, with the second extracellular loop being expressed with CD4 on the surface of cells derived from several tissues and species (Alkhatib et al., 1996 ; Choe especially critical.
The next set of four chimeras each contains two regions et Deng et al., 1996; Dragic et al., 1996) , it remains possible that cellular context could affect fusion from hCCR-5 and two from mCCR-5 (Figure 1 ) and includes three chimeras (MMHH, MHMH and HMMH) efficiency. To test this hypothesis, we repeated the experiments shown in Figure 4A and B using a different cell in which two of the first three extracellular domains of hCCR-5 are substituted with murine sequences while the line, i.e. human 293T cells instead of simian COS cells. As shown in Figure 5 , this difference in cell surface fourth cassette, containing the invariant third extracellular loop ( Figure 1A) , remains of human origin. As predicted environment had little effect on the efficiency of cell fusion observed with the various hCCR-5-mCCR-5 chimeras and by the earlier observation that either the amino-terminal tail or the second extracellular loop of hCCR-5 is sufficient the ADA and BaL envelope proteins. However, the MHMH chimera did seem to function somewhat more efficiently to mediate efficient fusion by the ADA envelope, the three chimeras MMHH, HMMH and HMHM were each found with the ADA envelope protein, and the HMMH chimera somewhat more effectively with the BaL envelope, when to be essentially as effective as parental hCCR-5 in mediating ADA envelope fusion ( Figure 4A ). The observexpressed on 293T cells ( Figure 5 ) when compared with COS cells (Figure 4 ). While the basis for these minor ation that the MHMH chimera also gave a low but significant level of activity with ADA clearly demonstrates differences is not clear, FACS analysis does indicate that 293T cells express somewhat higher levels of chemokine that the first extracellular loop of hCCR-5 also participates in the ADA envelope fusion process, although less receptors on their surface after transfection (data not shown). effectively than the amino-terminal tail or the second extracellular loop. Analysis of BaL envelope fusion revealed that the HMHM chimera also mediated the The V3 loop of HIV-1 envelope influences co-receptor usage activity of this viral protein efficiently. Given that the MMHM and HMMM chimeras earlier were found to be The data presented in Figures 4 and 5, and summarized in Table I , demonstrate that three different HIV-1 isolates inefficient or inactive in mediating BaL envelope fusion ( Figure 4B ), it was surprising that the similar MMHH and capable of utilizing hCCR-5 as a co-receptor, i.e. ADA, BaL and 89.6, nevertheless each have clearly distinct HMMH chimeras gave detectable, albeit low, levels of fusion with BaL, as these chimeras are predicted to share requirements for hCCR-5 binding, as revealed by the above analysis of hCCR-5-mCCR-5 chimera function. identical extracellular sequences. However, the MHMH chimera, which gave some activity with ADA, was found Previously, we and others have demonstrated that the V3 loop, an~35 amino acid disulfide-bonded protein domain to be entirely inactive with the BaL envelope ( Figure 4B ). It is of interest that the 89.6 dual-tropic envelope was within envelope gp120, is a major determinant of HIV-1 Fig. 6 . The V3 loop of HIV-1 envelope can modulate the CCR-5 co-receptor-envelope interaction. Co-receptor activity was assayed in Fig. 5 . Analysis of the hCCR-5-mCCR-5 co-receptor function in 293T COS cells as described in the text using the indicated, IIIB-derived V3 cells. These assays were performed essentially as described in Figure 4 loop substitution mutants. Data are presented as in Figure 4 . and are presented using the same format. cell tropism. In particular, substitution of the V3 loop ADA envelopes, was nevertheless distinct in that little if any fusion activity was observed with the HMMM chisequence from any one of several M-tropic viruses into the T-tropic IIIB envelope results in an M-tropic hybrid mera, and relatively low levels with the similar HMMH chimera. It is of interest that, while the parental BaL envelope that can interact functionally with the hCCR-5 co-receptor (Hwang et al., 1991; Westervelt et al., 1991;  envelope also gave no detectable activity with the HMMM chimera and only low levels with HMMH, both the ADA Choe et al., 1996) . It is of note that the V3 loop sequences in the M-tropic BaL and ADA isolates are very similar, and the IIIB-V3-ADA envelope gave readily detectable levels of fusion with both the HMMM and the HMMH differing only by a single conservative Phe→Leu change. In contrast, the T-tropic IIIB and the dual-tropic 89.6 co-receptor chimeras (Figures 4 and 6 , Table I ). It appears, therefore, that the sequence of the V3 loop not only isolates contain V3 loop sequences that diverge extensively from both the M-tropic ADA and BaL isolates and from confers, on the T-tropic IIIB envelope, the ability to interact with hCCR-5, but also that very minor changes in each other (Planelles et al., 1993) .
To examine whether minor differences in V3 loop the V3 loop can modulate this interaction in specific ways. sequences would affect the envelope-CCR-5 interaction, we next examined the ability of M-tropic envelope chiDiscussion meras, consisting of the ADA and BaL V3 loops substituted into the IIIB envelope context , While the cell surface CD4 glycoprotein represents the primary receptor for HIV-1, CD4 alone is not sufficient to mediate fusion with the various hCCR-5-mCCR-5 receptor chimeras ( Figure 6 , Table I ). Because the results to mediate infection. Instead, fusion of the HIV-1 envelope with target cells also requires a functional interaction with using COS and 293T cells showed no significant cellular context effect on efficiency of fusion (Figures 4 and 5) , a co-receptor that belongs to the chemokine receptor family of seven-membrane-spanning, G-protein-coupled these studies were performed exclusively in COS cells. The IIIB-V3-ADA chimera behaved in these assays largely receptors (Alkhatib et al., 1996; Choe et al., 1996; Deng et al., 1996; Doranz et al., 1996; Dragic et al., 1996 ; Feng indistinguishably from the ADA envelope itself. In particular, the IIIB-V3-ADA envelope, like the ADA envelope, et al., 1996) . Two chemokine receptors, the CCR-5 coreceptor for M-tropic HIV-1 isolates and the CXCR-4 cogave rise to readily detectable levels of fusion with the HMMM and MMHM chimeras that each contain only a receptor for T-tropic isolates, have now been shown to represent by far the most prevalent co-receptors for HIV-1 single hCCR-5 extracellular domain in an otherwise entirely mCCR-5 context. In contrast, the IIIB-V3-BaL (Zhang et al., 1996) , although two isolates able to utilize CCR-3 and one capable of utilizing CCR-2b have also chimera gave rise to an activity pattern that, while generally similar to the patterns seen with the ADA and IIIB-V3-been described (Choe et al., 1996; Doranz et al., 1996) .
While little is known as yet about how CCR-5 or CXCR-4 expressing cells (Table I) . Therefore, it is apparent that the first and third extracellular domains of hCCR-5 are mediate virion entry, evidence has been presented suggesting that the co-receptor forms a ternary complex with each fully sufficient to induce ADA envelope-induced cell fusion when expressed in the otherwise non-permissive CD4 and gp120 on the surface of target cells (Lapham et al., 1996; Trkola et al., 1996; Wu et al., 1996) . mCCR-5 context, while the second extracellular domain of hCCR-5 is at least partially active. Here we have attempted to answer two questions relevant to understanding the functional interaction Analysis of the BaL M-tropic envelope produced a significantly different set of data (Table I) . Although the between CCR-5 and M-tropic HIV-1 envelopes. These are (i) which extracellular regions of the hCCR-5 receptor BaL envelope, like the ADA envelope, was able to interact efficiently with chimeras in which any single human contribute to this interaction? and (ii) do different M-tropic HIV-1 envelope proteins interact with hCCR-5 in the same sequence was substituted with that of mouse (i.e. MHHH, HMHH and HHMH), BaL was not able to interact way? Our approach to these questions involved generating a set of chimeras between the permissive human CCR-5 effectively with any of the three chimeras containing single human extracellular domain substitutions (HMMM, receptor and the very similar, yet non-permissive, murine CCR-5 molecule (Figure 1) . We then devised a rapid, MMHM and MHMH) that were utilized effectively by the ADA envelope. Curiously, the MMHH and HMMH quantitative assay that measures the ability of these chimeric receptor molecules to mediate fusion with cells chimeras, which should present extracellular sequences identical to MMHM and HMMM, did give a modest level expressing natural or artificial M-tropic (ADA, BaL, IIIB-V3-ADA, IIIB-V3-BaL), dual-tropic (89.6) or T-tropic of fusion with the BaL envelope, although this was again lower than seen with ADA. This suggests that the (IIIB) HIV-1 envelope proteins.
The hCCR-5 and mCCR-5 receptors differ significantly additional human sequences present in these two chimeras may either promote a conformation favorable to envelope in the amino-terminal extracellular tail and in the first and second extracellular loop, but are predicted to have an binding when present in cis or that they promote steps subsequent to binding that permit more efficient fusion to identical third extracellular loop (Figure 1) . Therefore, while these chimeras can shed light on the contribution occur. A final important point is that the HMHM chimera containing the first and third extracellular domain of of the three variable extracellular domains to hCCR-5 coreceptor function, they do not address whether the fourth hCCR-5 did promote efficient fusion with the BaL envelope (Table I) . Overall, these data suggest that, while extracellular domain plays any important role in this process. In considering these data, it is also important to no single extracellular domain of hCCR-5 is critical for BaL envelope fusion, no domain is sufficient either. remember that mCCR-5 derived sequences may well participate in the interaction with HIV-1 envelope when
Instead, these data demonstrate that any two of the first three human CCR-5 extracellular domains are required to in the context of an hCCR-5-mCCR-5 chimera. Thus, while a given hCCR-5 sequence may be sufficient to confer co-receptor function on mCCR-5 when challenged with the BaL envelope protein. mediate cell fusion when introduced into the otherwise non-permissive mCCR-5 receptor context, this does not Perhaps the most surprising data in this study were obtained with the dual-tropic 89.6 envelope protein, which necessarily imply that the introduced human sequence is sufficient to mediate the observed phenotype. Of the is able to use the very different CCR-5, CXCR-4, CCR-3 and CCR-2b molecules as co-receptors and has, as a original 14 hCCR-5-mCCR-5 receptor chimeras, 10 were found to be expressed efficiently on the surface of transresult, been termed a 'remarkably promiscuous' envelope protein . In contrast to this plasticity, fected cells and also retained the ability to be activated by the chemokine MIP-1 (Figure 3 ). Data obtained with 89.6 proved intolerant of almost any change in the hCCR-5 receptor (Table I ). In particular, and unlike ADA and these 10 hybrid molecules, as well as with the wild-type hCCR-5, MCCR-5 and hCXCR-4 receptors, are presented BaL, the 89.6 envelope interacted poorly with chimeras containing either the first or second mCCR-5 extracellular in Figures 4-6 and summarized in Table I. domain inserted into the hCCR-5 receptor (MHHH and HMHH) and failed entirely to interact with a chimera At least three extracellular domains of hCCR-5 are involved in co-receptor function containing the second mouse extracellular loop (HHMH). Therefore, it is apparent that the efficient interaction of The M-tropic ADA HIV-1 envelope protein proved able to interact functionally with every chimera tested, with the 89.6 envelope with the hCCR-5 co-receptor is dependent on the functional integrity of all three of the extracelluthe exception of MMMH, which is predicted to be identical in its extracellular sequence to the parental mCCR-5 lar domains of hCCR-5 examined here. Overall, the data discussed thus far indicate that all receptor (Table I) . Thus, ADA interacted very efficiently with chimeric receptors in which any one of the first three three of the envelope proteins examined, i.e. ADA, BaL and 89.6, functionally interact with not only the hCCR-5 extracellular domains of hCCR-5 was replaced with murine sequences (MHHH, HMHH and HHMH) and also interamino-terminal tail but also with the first and second extracellular loop. For the ADA envelope, the aminoacted very effectively with mCCR-5-based receptors containing only the first or the third extracellular domain of terminal tail and the second extracellular loop are fully sufficient, in the mCCR-5 context, to mediate efficient the human protein (HMMM and MMHM). Unfortunately, the MHMM chimera proved unstable and therefore could fusion, while the first extracellular loop can mediate partial activity. In contrast, for the 89.6 envelope, all three regions not be tested. However, the MHMH chimera, which differs from the non-permissive mCCR-5 and MMMH proteins, must be of human origin for efficient fusion to occur. Finally, the BaL envelope is intermediate in that no in extracellular terms, only in the first loop, did give rise to significant levels of fusion with ADA envelopesingle hCCR-5 extracellular domain is sufficient, yet any combination of two is fully active. Thus, BaL requires their laboratory-adapted counterparts, also retain the ability to use CCR-5 as a co-receptor (Simmons et al., 1996 ; any two extracellular hCCR-5 sequences, ADA requires any one sequence and 89.6 can only fuse efficiently if all Zhang et al., 1996) . In the same way, sequence divergence in the envelope protein in response to selective pressures three hCCR-5 extracellular domains are present.
imposed by anti-viral immune responses could be facilitated by the flexible nature of the functional interaction Sequences both inside and outside the V3 loop affect the envelope-co-receptor interaction between envelope and the CCR-5 co-receptor (McKnight et al., 1995) . This might be of particular importance to The finding that different HIV-1 envelope proteins can interact with the CCR-5 co-receptor in ways that are the V3 loop, which is not only a major target for neutralizing antibody but also, as shown here, specifically apparently quite different in molecular detail raises the questions of which regions of envelope participate in the involved in regulation of the envelope-CCR-5 interaction. Two recent reports, one published immediately prior to hCCR-5 interaction. It is well established that the~35 amino acid V3 loop of the envelope is the major, albeit submission of this manuscript and one shortly after (Atchison et al., 1996) , have also not the only, determinant of HIV-1 tropism (O'Brien et al., 1990; Hwang et al., 1991; Westervelt et al., 1991;  Boyd addressed the ability of chimeric chemokine receptors to function as co-receptors for HIV-1. Rucker et al. (1996 Rucker et al. ( ) et al., 1993 . We therefore asked how the V3 loop would affect the interaction of envelope proteins with the chimeric examined chimeras generated between hCCR-5 and human CCR-2b, a distinct chemokine receptor which has been receptors described here and, in particular, if the V3 loops of ADA and BaL, which differ by only a single shown to be functional with the dual-tropic 89.6 isolate but not with M-tropic HIV-1 isolates. That study also phenylalanine to leucine substitution (Planelles et al., 1993) , would exert a detectably different phenotype when documented the importance of both the amino-terminal domain and the first extracellular loop of CCR-5 in inserted into an identical, IIIB-derived envelope context.
As shown in Figure 6 and summarized in Table I , this infection by both M-and dual-tropic HIV-1 envelopes and, most importantly, was able to show that these different was indeed shown to be the case. Thus, while the IIIB-V3-ADA envelope protein was able to utilize the HMMH isolates interacted with different sub-regions of the CCR-5 receptor during the infection process. However, Rucker chimera efficiently, and the similar HMMM with some effectiveness, the IIIB-V3-BaL envelope proved entirely et al. (1996) did not observe any differences in the ability of different M-tropic HIV-1 isolates to use their panel of unable to interact functionally with HMMM and gave only partial activity with HMMH. Importantly, the level hCCR-5-hCCR-2b chimeras, and also did not report any evidence to support the critical role for the second of activity observed for IIIB-V3-BaL is identical to the pattern seen with these two co-receptor chimeras upon extracellular loop documented by our data (Table I) . While the basis for these differences is unclear, these two studies challenge with the parental BaL envelope (Table I) . As IIIB-V3-ADA and IIIB-V3-BaL differ by only a single examined chimeras constructed using a very different partner for hCCR-5 (mCCR-5 in this report, hCCR-2b in amino acid, it appears that this point mutation has specifically compromised the ability of the IIIB-V3-BaL envelope the earlier report) and also used different HIV-1 isolates. The recent study by Atchison et al. (1996) examined a to interact functionally with the amino-terminal extracellular domain of hCCR-5. It is of interest that the limited panel of not only hCCR-5-hCCR-2b but also hCCR-5-mCCR-5 chimeras, and is similar to the current IIIB-V3-BaL virus is, however, similar to ADA and to IIIB-V3-ADA in being able to interact efficiently with study in that multiple extracellular domains of hCCR-5 were shown to contribute to efficient infection by M-tropic both the MMHM and the MMHH chimera, both of which are used relatively poorly by BaL (Table I) . It would HIV-1. However, these two studies differ in that chimeras equivalent to our HMMM and MMHM constructs were appear, therefore, that the effectiveness of the interaction between HIV-1 envelope proteins and the third extracellueach reported by Atchison et al. (1996) to mediate relatively efficient infection by HIV-1 BaL, the only isolate lar domain of hCCR-5 is regulated, at least in part, by sequences outside of the V3 loop. they examined. In contrast, while we observed efficient utilization of these chimeric receptor constructs by the In conclusion, we have shown that the first, second and third extracellular domains of hCCR-5 all participate in ADA HIV-1 envelope, the BaL envelope proved ineffective ( Figure 4A and B). This discrepancy clearly could the functional interaction with HIV-1 envelope and have further shown that the relative contribution of each of result from differences in the assay system used in these two studies, in that Atchison et al. (1996) measured these hCCR-5 sequences to the process of membrane fusion is HIV-1 isolate dependent. Clearly, the existence infection by cell-free virus, while here we quantified the level of envelope-mediated cell membrane fusion. of multiple, functionally redundant gp120 contact sites on CCR-5, as well as the observed plasticity of the envelopeHowever, evidence from several studies (Clapham et al., 1991; Deng et al., 1996; Doranz et al., 1996; Dragic et al., CCR-5 interaction, could have important consequences in vivo. In particular, while sequence variation in the 1996; Rucker et al., 1996) has shown that the receptor requirements for HIV-1 envelope-mediated virion-cell envelope clearly influences the way in which M-tropic envelopes interact with the wild-type human CCR-5 cofusion are equivalent to the requirements for cell-cell fusion. More probably, this difference results from the receptor, this variation does not appear to compromise this interaction significantly. Thus, the potential exists for fact that Atchison et al. (1996) utilized an uncloned, and probably heterogeneous, stock of the BaL HIV-1 isolate, HIV-1 mutants to arise in vivo that have gained the ability to use alternative co-receptors, yet still retain their ability which has been in culture for Ͼ10 years (Gartner et al., 1986) , while we utilized a cloned BaL envelope gene. In to use CCR-5. Indeed, recent evidence suggests that most freshly isolated CXCR-4-utilizing virus strains, unlike any event, this minor discrepancy does not affect, and
Assay for cAMP production even serves to confirm, the finding that the interaction Human 293T cells were transfected with pCMV5-based parental or between the HIV-1 envelope and chemokine receptors is chimeric CCR-5 expression plasmids and with a pCMV5-based plasmid complex.
expressing adenylyl cyclase type V (Ishikawa et al., 1992) . At 48 h after transfection, cultures were labeled with 1 μCi/ml of [2, H]adenine, in minimal essential medium supplemented with 5% fetal bovine serum.
Materials and methods
The cells were then washed with fresh medium containing 10 mM HEPES (pH 7.4) and 0.2% bovine serum albumin (BSA), treated with Construction of molecular clones 1 mM 3-isobutyl-1-methylxanthine (IBMX) for 15 min, and then cDNA clones encoding human CCR-5 and CXCR-4, as well as the stimulated with 1 μM forskolin, alone or with 100 nM MIP-1β. After murine CCR-5 homolog, were obtained by PCR using a human T-cell incubation for 30 min at 37°C, the medium was aspirated, and the cDNA library or mouse genomic DNA as templates. In each case, the reaction was terminated by addition of 2.5% percholic acid, 0.1 mM 5Ј primer introduced an NcoI restriction site underlying the translation cAMP and 4 nCi/ml of [ 14 C]cAMP. The cAMP levels were then initiation codon. Subsequently, a sequence encoding the nine amino acid quantitated as described previously (Salomon, 1991) . influenza HA-derived epitope tag (NH 2 -YPYDVPDYA-COOH) (Wilson et al., 1984) was inserted between CCR-5 or CXCR-4 amino acid residues 2 and 3 by PCR. The 3Ј PCR primers introduced unique XhoI
